TLR2 ligation protects effector T cells from regulatory T-cell mediated suppression and repolarizes T helper responses following MVA-based cancer immunotherapy
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TLR2 ligation protects effector T cells from regulatory T-cell mediated suppression and repolarizes T helper responses following MVA-based cancer immunotherapy
Authors
Keywords
-
Journal
OncoImmunology
Volume 1, Issue 8, Pages 1271-1280
Publisher
Informa UK Limited
Online
2012-09-19
DOI
10.4161/onci.21479
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2011: the immune hallmarks of cancer
- (2011) Federica Cavallo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IL-17 + Regulatory T Cells in the Microenvironments of Chronic Inflammation and Cancer
- (2011) Ilona Kryczek et al. JOURNAL OF IMMUNOLOGY
- TLR2 Stimulation Drives Human Naive and Effector Regulatory T Cells into a Th17-Like Phenotype with Reduced Suppressive Function
- (2011) M. H. Nyirenda et al. JOURNAL OF IMMUNOLOGY
- TLR1/TLR2 Agonist Induces Tumor Regression by Reciprocal Modulation of Effector and Regulatory T Cells
- (2011) Y. Zhang et al. JOURNAL OF IMMUNOLOGY
- Regulatory T Cells
- (2010) Tatiana N. Golovina et al. CANCER JOURNAL
- T regulatory cells in cancer: recent advances and therapeutic potential
- (2010) Eyad Elkord et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Toll-like Receptor 2 Signaling in CD4+ T Lymphocytes Promotes T Helper 17 Responses and Regulates the Pathogenesis of Autoimmune Disease
- (2010) Joseph M. Reynolds et al. IMMUNITY
- Differential but Direct Abolishment of Human Regulatory T Cell Suppressive Capacity by Various TLR2 Ligands
- (2010) H. H. Oberg et al. JOURNAL OF IMMUNOLOGY
- Induction of Th17 Cells in the Tumor Microenvironment Improves Survival in a Murine Model of Pancreatic Cancer
- (2010) J. L. Gnerlich et al. JOURNAL OF IMMUNOLOGY
- Clinical Use of Anti-CD25 Antibody Daclizumab to Enhance Immune Responses to Tumor Antigen Vaccination by Targeting Regulatory T cells
- (2009) Andrew J. Rech et al. Annals of the New York Academy of Sciences
- Plasticity of CD4+ FoxP3+ T cells
- (2009) Xuyu Zhou et al. CURRENT OPINION IN IMMUNOLOGY
- Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
- (2009) Ethan M. Shevach IMMUNITY
- Regulatory T cells and immune tolerance to tumors
- (2009) Xuefang Cao IMMUNOLOGIC RESEARCH
- STAT6 Activation Confers upon T Helper Cells Resistance to Suppression by Regulatory T Cells
- (2009) B. B. L. Pillemer et al. JOURNAL OF IMMUNOLOGY
- IL-6 Signaling in Psoriasis Prevents Immune Suppression by Regulatory T Cells
- (2009) W. A. Goodman et al. JOURNAL OF IMMUNOLOGY
- Engagement of TLR2 Does not Reverse the Suppressor Function of Mouse Regulatory T Cells, but Promotes Their Survival
- (2009) Q. Chen et al. JOURNAL OF IMMUNOLOGY
- Innate Immune Sensing of Modified Vaccinia Virus Ankara (MVA) Is Mediated by TLR2-TLR6, MDA-5 and the NALP3 Inflammasome
- (2009) Julie Delaloye et al. PLoS Pathogens
- Tumor-specific Th17-polarized cells eradicate large established melanoma
- (2008) P. Muranski et al. BLOOD
- Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells
- (2008) H. J. P. M. Koenen et al. BLOOD
- DC activated via dectin-1 convert Treg into IL-17 producers
- (2008) Fabiola Osorio et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Clinical development of MVA-based therapeutic cancer vaccines
- (2008) Bruce Acres et al. Expert Review of Vaccines
- Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity
- (2008) Nicole Asprodites et al. FASEB JOURNAL
- Autoantibodies to tumor-associated antigens: reporters from the immune system
- (2008) Eng M. Tan et al. IMMUNOLOGICAL REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now